Danaher Corp. stock gains support from UBS buy rating and July earnings beat
Published on 09/09/2026 at 12:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danaher Corp. stock (ISIN US2358511028) is trading close to USD 205.23 on the New York Stock Exchange as of September 8, 2026, leaving the shares below the average analyst target of around USD 228.91 and setting up a valuation gap that investors are watching closely.
UBS coverage adds a fresh buy signal
As Investing.com reported on September 9, 2026, UBS analyst Douglas Schenkel initiated coverage on Danaher Corp. with a buy rating and a price target of USD 250.00, which implies significant upside from the current trading level of USD 205.23.
According to Investing.com, Wall Street analysts maintain a consensus buy recommendation on Danaher with price targets that range between USD 195 and USD 310, underscoring that UBS sits toward the upper half of the current target spectrum.
July quarter results beat expectations
Danaher’s latest reported figures come from its July 20, 2026 quarter, which still forms the fundamental backdrop for the stock as of September 9, 2026. According to MarketBeat, Danaher reported earnings per share of USD 1.94 for that quarter, beating the consensus estimate of USD 1.85 by USD 0.09.
In the same report, MarketBeat noted that Danaher generated revenue of USD 6.26 billion in the July quarter, ahead of analyst expectations of USD 6.12 billion and up 5.5 percent year over year from the prior-year quarter.
The same July quarter data show that Danaher delivered a return on equity of 11.04 percent and a net margin of 15.95 percent, according to MarketBeat, underlining that the earnings beat was supported by both top-line growth and solid profitability.
Consensus and valuation context
Beyond UBS, Danaher’s broader analyst backdrop is supportive. According to MarketBeat, one investment analyst currently rates the stock Strong Buy, nineteen assign a Buy rating and five recommend Hold, yielding an average rating of Moderate Buy and an average price target of USD 228.91.
For investors, the quantified gap between price and targets is important: at a closing price of USD 205.23 on September 8, 2026, per Forbes, the shares trade roughly USD 23.68 below the USD 228.91 average target cited by MarketBeat, while the UBS target of USD 250.00 stands USD 44.77 above that latest close.
According to MarketBeat, Danaher’s shares have traded between a 52-week low of USD 160.93 and a 52-week high of USD 242.80, placing the September 8, 2026 closing level of USD 205.23 comfortably above the low but still well below the high.
Stock level and market data
Per price data summarised by Forbes, Danaher stock closed at USD 205.23 on the New York Stock Exchange on September 8, 2026, after trading in a daily range between USD 202.12 and USD 207.84 on a volume of 3,238,295 shares.
The same Forbes overview shows that the consensus revenue expectation for the current year stands at approximately USD 27.69 billion with a consensus EPS around USD 8.85, indicating that the July 20, 2026 quarter’s revenue of USD 6.26 billion and EPS of USD 1.94 are broadly aligned with the longer-term trajectory.
Danaher Corp. stock key data
- Company: Danaher Corp.
- ISIN: US2358511028
- Ticker: DHR
- Trading venue: NYSE
- Price (as of September 8, 2026, 16:00): 205.23 USD
- Market capitalization: 145.84 billion USD (as of September 4, 2026)
- Sector / Industry: Health care equipment and life sciences
- Index membership: S&P 500
